Keywords: map, elan, extend, resp, drug, accord, usa

MAP and Elan extend resp drug R&D accord

Article | 08 August 2005

Print This

The USA's MAP Pharmaceuticals has amended its previous agreement with Irish drugmaker Elan, signed in 2004, seeking to apply the latter's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in